American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Thumbnail

Cardiologists say FTC’s noncompete clause proposal could ‘impact every cardiovascular professional in the US’

“Without a doubt, this proposal created strong feelings across our membership," ACC President B. Hadley Wilson, MD, said in a statement. 

Sunil Rao, MD, FSCAI, 2022-23 President of the Society of Cardiovascular Angiography and Interventions (SCAI), and director of interventional cardiology NYU Langone, explains efforts by SCAI to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers (ASC).

Maintaining quality is key as more cardiac procedures migrate to outpatient ASCs

SCAI President Sunil Rao, MD, discussed the group's efforts to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers.

Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

SCAI President Sunil Rao, MD, explains the 2022-2023 SCAI accomplishments to improve interventional cardiology.

SCAI President Sunil Rao on how the society is helping advance interventional cardiology

Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

SCAI President Sunil Rao explains what he saw as the top 5 interventional studies at ACC23. #SCAI #ACC #ACC23

5 studies that could make a big impact on interventional cardiology

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

Echocardiography expert Patricia A. Pellikka, MD, discussed the trend of increasing artificial intelligence (AI) integration in cardiac ultrasound with Cardiovascular Business at American College of Cardiology (ACC) 2023 meeting.

AI's growing impact on echocardiography

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

Atul Verma explains thne results of the PULSE-AF trial at ACC23.

Pulsed-field ablation could be the next big EP technology trend

Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

ACC Vice President Cathie Biga discusses OBLs and ASCs during the ACC23 meeting. #ACC #OBLs #ASCs #ACC23

What the rise of outpatient cardiac OBLs and ASCs means for cardiology

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.